These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 27293058)

  • 21. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
    Manikandan M; Deva Magendhra Rao AK; Arunkumar G; Manickavasagam M; Rajkumar KS; Rajaraman R; Munirajan AK
    Mol Cancer; 2016 Apr; 15():28. PubMed ID: 27056547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer.
    Vilquin P; Donini CF; Villedieu M; Grisard E; Corbo L; Bachelot T; Vendrell JA; Cohen PA
    Breast Cancer Res; 2015 Jan; 17(1):13. PubMed ID: 25633049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of miRNA-9 and miRNA-34a as potential biomarkers for diagnosis of breast cancer in Iranian women.
    Orangi E; Motovali-Bashi M
    Gene; 2019 Mar; 687():272-279. PubMed ID: 30468908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and clinical significance of miRNAs that may be associated with the FHIT gene in breast cancer.
    Sevinc ED; Cecener G; Ak S; Tunca B; Egeli U; Gokgoz S; Tolunay S; Tasdelen I
    Gene; 2016 Sep; 590(2):278-84. PubMed ID: 27236032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deregulation of cancer-related miRNAs is a common event in both benign and malignant human breast tumors.
    Tahiri A; Leivonen SK; Lüders T; Steinfeld I; Ragle Aure M; Geisler J; Mäkelä R; Nord S; Riis ML; Yakhini Z; Kleivi Sahlberg K; Børresen-Dale AL; Perälä M; Bukholm IR; Kristensen VN
    Carcinogenesis; 2014 Jan; 35(1):76-85. PubMed ID: 24104550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Down-regulated microRNA-124 expression as predictive biomarker and its prognostic significance with clinicopathological features in breast cancer patients.
    Arabkheradmand A; Safari A; Seifoleslami M; Yahaghi E; Gity M
    Diagn Pathol; 2015 Sep; 10():178. PubMed ID: 26415857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-21: A gene of dual regulation in breast cancer.
    Zhang C; Liu K; Li T; Fang J; Ding Y; Sun L; Tu T; Jiang X; Du S; Hu J; Zhu W; Chen H; Sun X
    Int J Oncol; 2016 Jan; 48(1):161-72. PubMed ID: 26549725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased expression of MicroRNA-200 family in human breast cancer is associated with lymph node metastasis.
    Xu F; He H; Huang W; Lin Y; Luo S; Du Q; Duan R
    Clin Transl Oncol; 2016 Mar; 18(3):283-8. PubMed ID: 26201425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features.
    Wang B; Li J; Sun M; Sun L; Zhang X
    IUBMB Life; 2014 May; 66(5):371-7. PubMed ID: 24846313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MACE-Seq-based coding RNA and TrueQuant-based small RNA profile in breast cancer: tumor-suppressive miRNA-1275 identified as a novel marker.
    Majed SO; Mustafa SA
    BMC Cancer; 2021 Apr; 21(1):473. PubMed ID: 33910530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of Specific miRNA Signature in Paired Sera and Tissue Samples of Indian Women with Triple Negative Breast Cancer.
    Thakur S; Grover RK; Gupta S; Yadav AK; Das BC
    PLoS One; 2016; 11(7):e0158946. PubMed ID: 27404381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased expression of microRNA-124 is an independent unfavorable prognostic factor for patients with breast cancer.
    Dong LL; Chen LM; Wang WM; Zhang LM
    Diagn Pathol; 2015 Apr; 10():45. PubMed ID: 25924779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aberrant Expression of PIWIL1 and PIWIL2 and Their Clinical Significance in Ductal Breast Carcinoma.
    Litwin M; Szczepańska-Buda A; Michałowska D; Grzegrzółka J; Piotrowska A; Gomułkiewicz A; Wojnar A; Dzięgiel P; Witkiewicz W
    Anticancer Res; 2018 Apr; 38(4):2021-2030. PubMed ID: 29599319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression Analysis of Previously Verified Fecal and Plasma Dow-regulated MicroRNAs (miR-4478, 1295-3p, 142-3p and 26a-5p), in FFPE Tissue Samples of CRC Patients.
    Ghanbari R; Rezasoltani S; Hashemi J; Mohamadkhani A; Tahmasebifar A; Arefian E; Mobarra N; Asadi J; Nazemalhosseini Mojarad E; Yazdani Y; Knuutila S; Malekzadeh R
    Arch Iran Med; 2017 Feb; 20(2):92-95. PubMed ID: 28193082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TIP60-miR-22 axis as a prognostic marker of breast cancer progression.
    Pandey AK; Zhang Y; Zhang S; Li Y; Tucker-Kellogg G; Yang H; Jha S
    Oncotarget; 2015 Dec; 6(38):41290-306. PubMed ID: 26512777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer.
    Tan X; Fu Y; Chen L; Lee W; Lai Y; Rezaei K; Tabbara S; Latham P; Teal CB; Man YG; Siegel RS; Brem RF; Fu SW
    Oncotarget; 2016 Jan; 7(1):293-307. PubMed ID: 26588055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel Biomarkers for Non-functioning Invasive Pituitary Adenomas were Identified by Using Analysis of microRNAs Expression Profile.
    Wu S; Gu Y; Huang Y; Wong TC; Ding H; Liu T; Zhang Y; Zhang X
    Biochem Genet; 2017 Jun; 55(3):253-267. PubMed ID: 28315020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of serum genome-wide microRNAs for breast cancer detection.
    Wu Q; Wang C; Lu Z; Guo L; Ge Q
    Clin Chim Acta; 2012 Jul; 413(13-14):1058-65. PubMed ID: 22387599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hsa-miR-1 suppresses breast cancer development by down-regulating K-ras and long non-coding RNA MALAT1.
    Liu R; Li J; Lai Y; Liao Y; Liu R; Qiu W
    Int J Biol Macromol; 2015 Nov; 81():491-7. PubMed ID: 26275461
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinico-pathologic role of microRNAs miR-9 and miR-151-5p in breast cancer metastasis.
    Krell J; Frampton AE; Jacob J; Pellegrino L; Roca-Alonso L; Zeloof D; Alifrangis C; Lewis JS; Jiao LR; Stebbing J; Castellano L
    Mol Diagn Ther; 2012 Jun; 16(3):167-72. PubMed ID: 22489664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.